SCHEMBL5320301

SCHEMBL5320301

CC[C@H]1CC[C@H]2[C@@H]3CCC4CC=CC[C@@H]4[C@H]3CC[C@]12C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.40
GRIN2B Q13224 2/20 0.40
GABRP O00591 11/20 0.36
GABRD O14764 11/20 0.36
GABRA1 P14867 11/20 0.36
GABRB1 P18505 11/20 0.36
GABRG2 P18507 11/20 0.36
GABRB3 P28472 11/20 0.36
GABRA5 P31644 11/20 0.36
GABRA3 P34903 11/20 0.36
GABRA2 P47869 11/20 0.36
GABRB2 P47870 11/20 0.36
GABRA4 P48169 11/20 0.36
GABRE P78334 11/20 0.36
GABRA6 Q16445 11/20 0.36
GABRG1 Q8N1C3 11/20 0.36
GABRG3 Q99928 11/20 0.36
GABRQ Q9UN88 11/20 0.36
SHBG P04278 1/20 0.36
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22072638 0.81 GABRP (0.46) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL28139742 0.81 GRIN1 (0.41) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL1173075 0.81 GRIN1 (0.41) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL7889098 0.80 GRIN1 (0.39) GRIN1GRIN2BCYP3A4
SCHEMBL9679418 0.79 SHBG (0.57) SHBGCYP3A4
SCHEMBL7060738 0.79 GABRP (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL4385665 0.78 GRIN1 (0.42) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL22072807 0.78 GRIN1 (0.42) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL11578602 0.78 GRIN1 (0.39) GRIN1GRIN2BGABRPGABRDGABRA1
SCHEMBL5320300 0.78 GRIN1 (0.37) GRIN1GRIN2BGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862396-A4 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE POPULATION COUNCIL INC (US) 2000-09-06 EP claimed
EP-0862396-A1 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE THE POPULATION COUNCIL, INC. (US) 1998-09-09 EP claimed
WO-1998004220-A9 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE 1998-05-28 WO claimed
WO-1998004220-A1 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE THE POPULATION COUNCIL, INC. (US) 1998-02-05 WO claimed
EP-1244458-B1 WEIGHT PROMOTING COMPOSITION, METHOD, AND PRODUCT PHERIN PHARM INC (US) 2007-10-03 EP disclosed
EP-0862396-B1 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE POPULATION COUNCIL INC (US) 2005-03-16 EP disclosed
WO-2004101594-A1 NEW MONO-AND BISMETHYLENE-STEROID DERIVATIVES AND PROCESS FOR THEIR SYNTHESIS Richter Gedeon Vegyészeti Gyár Rt. (HU) 2004-11-25 WO disclosed
EP-0830369-B1 NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN PHARM INC (US) 2003-05-14 EP disclosed
US-6555531-B1 Administering pregnanes such as 21-methyl-19-norpregna-1,3,5(10)-trien-3-ol; treating cachexia, eating disorders, AIDS, and giving to athletes PHERIN PHARMACEUTICALS, INC. 2003-04-29 US disclosed
US-6242619-B1 BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE PHERIN PHARMACEUTICALS, INC. 2001-06-05 US disclosed
US-6180803-B1 STEROID DRUGS LABORATOIRE THERAMEX (MC) 2001-01-30 US disclosed
US-6180803-B1 STEROID DRUGS LABORATOIRE THERAMEX (MC) 2001-01-30 US disclosed
WO-1998004220-A9 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE 1998-05-28 WO disclosed
EP-0830369-A1 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS Pherin Pharmaceuticals, Inc. (US) 1998-03-25 EP disclosed
WO-1998004220-A1 INTRAVAGINAL RINGS WITH INSERTABLE DRUG-CONTAINING CORE THE POPULATION COUNCIL, INC. (US) 1998-02-05 WO disclosed
WO-1997027210-A1 NEW 19-NOR-PREGNENE DERIVATIVES LABORATOIRE THERAMEX (MC) 1997-07-31 WO disclosed
EP-0785212-A1 New 19-nor-pregnene derivatives LABORATOIRE THERAMEX (MC) 1997-07-23 EP disclosed
EP-0785212-A1 New 19-nor-pregnene derivatives LABORATOIRE THERAMEX (MC) 1997-07-23 EP disclosed
WO-1996040727-A9 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS 1997-01-30 WO disclosed
WO-1996040727-A1 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed